Prednisolone Oral Solution
"The U.S. Food and Drug Administration will complete its phase-out of all inhaler medical products containing chlorofluorocarbons (CFCs) by Dec. 31, 2013. This effort is to comply with an international treaty to protect the ozone layer by phasing "...
Prednisolone Oral Solution
Prednisolone Oral Solution Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Prednisolone sodium (prednisolone sodium phosphate oral solution) is a corticosteroid used to treat a wide variety of conditions including allergies, skin conditions, edema, endocrine disorders, ulcerative colitis, blood disorders, cancer, multiple sclerosis, eye diseases, lung diseases, and rheumatic diseases. This medication may be available in generic form. Common side effects include nausea, vomiting, loss of appetite, heartburn, trouble sleeping, increased sweating, or acne.
The initial dosage of prednisolone sodium phosphate oral solution may vary from 5 mL to 60 mL (5 to 60 mg prednisolone base) per day depending on the disease being treated. Prednisolone sodium may interact with barbiturates, phenytoin, ephedrine, rifampin, cyclosporine, estrogens, ketoconazole, warfarin, aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs), diuretics, amphotericin-B, digitalis, anticholinesterase drugs, certain vaccines, and anti-diabetic medications. Tell your doctor all medications and supplements you use and all vaccines you recently received. During pregnancy, prednisolone sodium should be used only if prescribed. Prednisolone sodium passes into breast milk and may harm a nursing baby. Consult your doctor before breastfeeding.
Our Prednisolone sodium (prednisolone sodium phosphate oral solution) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Prednisolone Oral Solution FDA Prescribing Information: Side Effects
(listed alphabetically under each subsection):
Cardiovascular: Hypertrophic cardiomyopathy in premature infants.
Endocrine: Decreased carbohydrate tolerance; development of cushingoid state; hirsutism; increased requirements for insulin or oral hypoglycemic agents in diabetic patients; manifestations of latent diabetes mellitus; menstrual irregularities; secondary adrenocortical and pituitary unresponsiveness, particularly in times of stress, as in trauma, surgery or illness; suppression of growth in children.
Gastrointestinal: Abdominal distention; elevation in serum liver enzyme levels (usually reversible upon discontinuation); pancreatitis; peptic ulcer with possible perforation and hemorrhage; ulcerative esophagitis.
Musculoskeletal: Aseptic necrosis of femoral and humeral heads; loss of muscle mass; muscle weakness; osteoporosis; pathologic fracture of long bones; steroid myopathy; tendon rupture; vertebral compression fractures.
Read the entire FDA prescribing information for Prednisolone Oral Solution (Prednisolone Sodium Phosphate Oral Solution) »
Additional Prednisolone Oral Solution Information
Report Problems to the Food and Drug Administration
Allergies & Asthma
Improve treatments & prevent attacks.